跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ALDURAZYME laronidase (rch) 500U/5mL injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
ALDURAZYME laronidase (rch) 500U/5mL injection vial
Approved
STANDARD
ALDURAZYME laronidase (rch) 500U/5mL injection vial
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
1f6035f81c3aa301
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
1f6035f81c3aa301
Product Name
ALDURAZYME laronidase (rch) 500U/5mL injection vial
Artg Id
100847
Artg Name
ALDURAZYME laronidase (rch) 500U/5mL injection vial
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2004-05-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/4c8d04b3058e43436e3f5054306c61b6.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/50c3dc414cfe55872035a56edf8aafde.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
1f6035f81c3aa301
Type
Standard
Back to TGA Approvals